Search research articles
Contact Us
Filters
Showing results (21-30 of 87) with videos related to
Page
of 9
Sort By:
Journal of Neurointerventional Surgery
|
September 28, 2014
Hemorrhagic collision metastasis in a cerebral arteriovenous malformation
Dinesh K Sundarakumar, Desiree A Marshall, C Dirk Keene, et al.
JAAD Case Reports
|
March 10, 2020
Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
Cesar A Virgen, Tuyet A Nguyen, Cosimo Di Raimondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2019
Reply to A. Shinde et al
Harriet M Kluger, Kim A Margolin, Michael A Davies, et al.
Journal of the American Academy of Dermatology
|
May 1, 2021
Tumor-infiltrating lymphocytes are associated with improved survival in node-positive Merkel cell carcinoma: A national cohort analysis
Amy R Copeland, Mackenzie L Shindorf, James D McDonald, et al.
International Journal of Clinical Oncology
|
March 25, 2011
A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma
Derek Shek, Jeff Longmate, David I Quinn, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2011
Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin
Ahmad A Tarhini, Paul Frankel, Kim A Margolin, et al.
Annals of Surgical Oncology
|
September 10, 2020
Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling
James P De Andrade, Paul Wong, Michael P O'Leary, et al.
Investigational New Drugs
|
October 23, 2010
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial
Tianhong Li, Scott D Christensen, Paul H Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438)
Kim A Margolin, James Moon, Lawrence E Flaherty, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 87) with videos related to
Sort By:
Page
of 9
Journal of Neurointerventional Surgery
|
September 28, 2014
Hemorrhagic collision metastasis in a cerebral arteriovenous malformation
Dinesh K Sundarakumar, Desiree A Marshall, C Dirk Keene, et al.
JAAD Case Reports
|
March 10, 2020
Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
Cesar A Virgen, Tuyet A Nguyen, Cosimo Di Raimondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2019
Reply to A. Shinde et al
Harriet M Kluger, Kim A Margolin, Michael A Davies, et al.
Journal of the American Academy of Dermatology
|
May 1, 2021
Tumor-infiltrating lymphocytes are associated with improved survival in node-positive Merkel cell carcinoma: A national cohort analysis
Amy R Copeland, Mackenzie L Shindorf, James D McDonald, et al.
International Journal of Clinical Oncology
|
March 25, 2011
A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma
Derek Shek, Jeff Longmate, David I Quinn, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2011
Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin
Ahmad A Tarhini, Paul Frankel, Kim A Margolin, et al.
Annals of Surgical Oncology
|
September 10, 2020
Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling
James P De Andrade, Paul Wong, Michael P O'Leary, et al.
Investigational New Drugs
|
October 23, 2010
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial
Tianhong Li, Scott D Christensen, Paul H Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438)
Kim A Margolin, James Moon, Lawrence E Flaherty, et al.
Page
of 9